Agency Interactions
Sucessfully submit your application for drug approval to the competent authorities.
At QbD Austria we help you to interact with the required health agencies.
![Agency Interactions](https://at.qbdgroup.com/wp-content/uploads/2023/09/agency-interactions-1024x684.jpg)
Preparation and communication
Agency interactions play a central role in the drug approval process. For example, in the European Union (EU), a company that wishes to bring a pharmaceutical to the market must submit an application to the competent authority or the European Medicines Agency (EMEA) for a ‘marketing authorisation’ (licence).
In case of the Centralised Procedure an application is made to the EMEA. For all other procedures – National, Mutual Recognition Procedure (MRP) and/or a Decentralised Procedure (DCP) – an application must be made to the national competent authority(ies).
Our team of experienced consultants help you to interact with all relevant health authorities.
How we support you
- Initiate contact with the relevant authorities
- Prepare briefing packages
- Moderate authority meetings
- Dossier (CMC) guidance
Why opt for the QbD Group?
EXCEPTIONAL RA SERVICES THAT MEET YOUR NEEDS
10+ years of experience
Benefit from our team of highly qualified consultants.
Full life cycle support
Full support from pre- to the post-marketing phase.
Global presence
QbD operates globally, at QbD Austria with a special focus on Europe (EU) and China.
Customer satisfaction
Constant evaluation, transparency and clear objectives.
Contact us
Talk to an expert
Contact us for more information or to request a free, no-obligation proposal.